Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC)

التفاصيل البيبلوغرافية
العنوان: Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC)
المؤلفون: Richard F. Kefford, Darcy A. Hille, Patrick Chun, Richard W. Joseph, Peter Hersey, Jeffrey S. Weber, Anthony M. Joshua, Caroline Robert, Omid Hamid, Hassane M. Zarour, Dahai Xue, Andrea Marie Perrone, Jedd D. Wolchok, Roxana S. Dronca, Wen-Jen Hwu, Antoni Ribas, Soonmo Peter Kang, F.S. Hodi, Adil Daud, Scot Ebbinghaus, Linda Gammage, Tara C. Gangadhar
المصدر: Journal for Immunotherapy of Cancer
بيانات النشر: BioMed Central, 2014.
سنة النشر: 2014
مصطلحات موضوعية: Pharmacology, Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Melanoma, Immunology, Ipilimumab, Pembrolizumab, Disease, Immunotherapy, Bioinformatics, medicine.disease, Internal medicine, Poster Presentation, medicine, Molecular Medicine, Immunology and Allergy, In patient, business, Advanced melanoma, Immune-Related Response Criteria, medicine.drug
الوصف: Meeting abstracts Unique patterns of response have been observed with immunotherapies. Notably, objective response and prolonged disease stabilization can occur after an initial increase in tumor burden. irRC were developed to better characterize response to immunotherapy based on data for
اللغة: English
تدمد: 2051-1426
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5777ee57628b14597090673daa246fd9Test
http://europepmc.org/articles/PMC4288385Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....5777ee57628b14597090673daa246fd9
قاعدة البيانات: OpenAIRE